Maldives Food and Drug Authority (MFDA) approves the Covishield vaccine donated by India for emergency use.
The statement released by MFDA reads that the emergency use of the Covishield vaccine is approved after technical considerations from the National Pharmaceutical Board. MFDA also stated that the Covishield vaccine shall only be administered to individuals above 18 years of age and it shall not be used on patients with severe allergies or immunocompromised patients, patients with underlying conditions such as heart conditions, or lung conditions.
As per the statement of MFDA, the Covishield vaccine is not approved for administration to pregnant women. MFDA also said that the individual recipients of the vaccine will be monitored by the MFDA, Health Ministry, and Health Protection Agency (HPA) for possible reactions.
The 100,000 doses of the Covishield vaccine arrived in the Maldives on January 20. Covishield is based on the Oxford-AstraZeneca vaccine, co-developed by the Oxford University and AstraZeneca to combat Covid-19. The Oxford-AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer.
The statement released by MFDA reads that the emergency use of the Covishield vaccine is approved after technical considerations from the National Pharmaceutical Board. MFDA also stated that the Covishield vaccine shall only be administered to individuals above 18 years of age and it shall not be used on patients with severe allergies or immunocompromised patients, patients with underlying conditions such as heart conditions, or lung conditions.
As per the statement of MFDA, the Covishield vaccine is not approved for administration to pregnant women. MFDA also said that the individual recipients of the vaccine will be monitored by the MFDA, Health Ministry, and Health Protection Agency (HPA) for possible reactions.
The 100,000 doses of the Covishield vaccine arrived in the Maldives on January 20. Covishield is based on the Oxford-AstraZeneca vaccine, co-developed by the Oxford University and AstraZeneca to combat Covid-19. The Oxford-AstraZeneca vaccine is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer.
